Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study is being carried out to see if dapagliflozin in addition to glimepiride
(sulphonylurea) is effective and safe in treating patients with type 2 diabetes when compared
to glimepiride alone.